IRIS
MASSIRONI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.196
NA - Nord America 1.116
EU - Europa 683
SA - Sud America 607
AF - Africa 38
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.643
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.039
SG - Singapore 903
CN - Cina 537
BR - Brasile 498
HK - Hong Kong 417
IT - Italia 297
VN - Vietnam 172
DE - Germania 90
AR - Argentina 45
GB - Regno Unito 45
SE - Svezia 38
MX - Messico 37
AT - Austria 32
IN - India 30
FR - Francia 29
PL - Polonia 27
CA - Canada 26
FI - Finlandia 26
RU - Federazione Russa 24
TR - Turchia 22
BD - Bangladesh 21
ES - Italia 21
NL - Olanda 21
ID - Indonesia 20
CO - Colombia 19
JP - Giappone 16
IQ - Iraq 15
ZA - Sudafrica 15
EC - Ecuador 14
VE - Venezuela 8
LT - Lituania 7
MA - Marocco 7
UY - Uruguay 7
DZ - Algeria 6
UA - Ucraina 6
CL - Cile 5
IE - Irlanda 5
JO - Giordania 5
PY - Paraguay 5
TW - Taiwan 5
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
BN - Brunei Darussalam 3
DO - Repubblica Dominicana 3
IL - Israele 3
JM - Giamaica 3
PE - Perù 3
SA - Arabia Saudita 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
CR - Costa Rica 2
CY - Cipro 2
KW - Kuwait 2
OM - Oman 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
KE - Kenya 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
RS - Serbia 1
SR - Suriname 1
SV - El Salvador 1
TH - Thailandia 1
TO - Tonga 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.643
Salva come PNG Salva come JPEG
Città #
Singapore 461
Dallas 442
Hong Kong 410
Hefei 159
Ashburn 116
Milan 90
Shanghai 86
Beijing 81
Ho Chi Minh City 65
São Paulo 53
New York 43
Los Angeles 35
Hanoi 34
Nuremberg 33
Warsaw 24
Rome 23
Mexico City 19
Munich 18
Turin 18
Brooklyn 17
Rio de Janeiro 17
Montreal 16
Tokyo 16
Naples 15
Stockholm 13
Amsterdam 12
Denver 12
Falkenstein 12
Poplar 12
Ankara 11
Atlanta 11
Boardman 11
London 11
Orem 11
Vienna 11
Brasília 10
Chennai 10
Curitiba 10
Helsinki 10
Charlotte 9
Chicago 9
Da Nang 9
Frankfurt am Main 9
Houston 9
Johannesburg 9
Lappeenranta 9
San Francisco 9
Assago 8
Buffalo 8
Haiphong 8
Santa Clara 8
Belo Horizonte 7
Bologna 7
Boston 7
Genoa 7
Manchester 7
Phoenix 7
Quito 7
Ribeirão Preto 7
Turku 7
Bogotá 6
Columbus 6
Lawrence 6
Moscow 6
Mumbai 6
Princeton 6
Querétaro 6
Stezzano 6
São Gonçalo 6
Amman 5
Apodaca 5
Baghdad 5
Dublin 5
Duque de Caxias 5
Guangzhou 5
Jakarta 5
Mauá 5
Miami 5
Porto Alegre 5
Salvador 5
Santo André 5
Seattle 5
Taipei 5
The Dalles 5
Tianjin 5
Bari 4
Brescia 4
Buenos Aires 4
Campos dos Goytacazes 4
Catania 4
Dhaka 4
Goiânia 4
Guarulhos 4
Guayaquil 4
Ha Long 4
Hải Dương 4
Jinan 4
Maceió 4
Montevideo 4
Natal 4
Totale 2.819
Salva come PNG Salva come JPEG
Nome #
Inflammation and malnutrition in inflammatory bowel disease 87
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 81
Unraveling the Microbiome's Role in Neuroendocrine Neoplasms: A New Perspective 57
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study 56
The Endoscopic Management of Anastomotic Strictures After Esophagogastric Surgery: A Comprehensive Review of Emerging Approaches Beyond Endoscopic Dilation 55
Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study 55
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 53
An esophageal gastrointestinal stromal tumor in a patient with MEN1-related pancreatic gastrinoma : an unusual association and review of the literature 53
Venous Thromboembolism in Patients with Neuroendocrine Neoplasms: A Systematic Review of Incidence, Types, and Clinical Outcomes 52
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence? 50
Acute mesenteric ischemia and small bowel imaging findings in COVID-19: A comprehensive review of the literature 50
Accuracy of Ultrasonography, Spiral CT, Magnetic Resonance, and Alpha-Fetoprotein in Diagnosing Hepatocellular Carcinoma: A Systematic Review: CME 50
ASO Author Reflections: Heterogeneity of Duodenal Neuroendocrine Tumors. 49
Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Assessment of Response to Treatment and Follow-Up in Gastroenteropancreatic Neuroendocrine Neoplasms 48
Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review 47
Occurrence and characteristics of endoscopic gastric polyps in patients with autoimmune gastritis (AGAPE study): A multicentric cross-sectional study 46
Beyond the gluten-free diet: Innovations in celiac disease therapeutics 45
Advancing transmural remission as a treatment target in Crohn's disease: The future of tight-control strategy? 44
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database 43
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors 43
Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor 43
Advancements in Barrett's esophagus detection: The role of artificial intelligence and its implications 42
A wait-and-watch approach to small pancreatic neuroendocrine tumors : Prognosis and survival 42
Advances in Endo-Hepatology: The Role of Endoscopic Ultrasound in the Management of Portal Hypertension 41
"Pseudotumoral” hepatic pattern in acute alcoholic hepatitis : a case report 41
Endoscopic ultrasound appearance of pancreatic serotonin-staining neuroendocrine neoplasms 40
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 39
Autoimmune pancreatitis: Cornerstones and future perspectives 39
Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? 38
Biochemical Markers for Neuroendocrine Tumors: Traditional Circulating Markers and Recent Development—A Comprehensive Review 38
Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms 38
Chromogranin A in diagnosing and monitoring patients with gastro-entero-pancreatic neuroendocrine neoplasms : a large series from a single institution 37
Duodenal neuroendocrine neoplasms: a still poorly recognized clinical entity 36
"Pseudotumoral" hepatic areas in acute alcoholic hepatitis: A computed tomography and histological study 36
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management 35
An unusual endoscopic feature in the duodenum of a young girl with intraluminal duodenal diverticulum 35
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials 35
Autoimmune gastritis: an organ-specific disease or a model of systemic autoimmunity? Parallels, divergences, and emerging insights 34
A case of positive 68Ga-DOTATOC-PET/CT pancreatic heterotopia mimicking an intestinal neuroendocrine tumor 34
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial 34
Heterogeneity of Duodenal Neuroendocrine Tumors: An Italian Multi-center Experience 34
Clinical impact of endoscopic ultrasonography on the management of neuroendocrine tumors: lights and shadows 34
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 33
Should patients with IBS be submitted to painful rectal distention in clinical practice? [1] 33
High rates of 30-day mortality in patients with cirrhosis and COVID-19 33
Endoscopic techniques for gastric neuroendocrine tumors: An update 33
Chromogranin A in the Follow-up of Gastroenteropancreatic Neuroendocrine Neoplasms: Is It Really Game Over? A Systematic Review and Meta-analysis. 33
Endoscopic Submucosal Dissection (ESD) for the Management of Fibrotic Non-Lifting Colorectal Lesions (NLCLs): Results from a Large Multicenter Retrospective Study 32
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study 32
IMP3 expression in small-intestine neuroendocrine neoplasms: a new predictor of recurrence 32
Systematic review-Pancreatic involvement in inflammatory bowel disease 32
COVID-19 in patients with neuroendocrine neoplasms: two-year results of the INTENSIVE study 31
Autoimmune Pancreatitis Mimicking a Pancreatic Neuroendocrine Tumor: A Case Report with a Literature Review 31
Endoscopic techniques for diagnosis and treatment of gastro-entero-pancreatic neuroendocrine neoplasms: Where we are 30
Drug side-effects in IBD [1] 30
Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm 30
Endoscopic Ultrasound Elastography in Pancreatic Diseases EUS-EG in Pancreatic Diseases 29
Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis 29
Circulating ghrelin levels in patients with inflammatory bowel disease [1] 29
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 29
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 28
Letter: Mendelian randomization - new perspective in inflammatory bowel disease and pancreatic cancer? Authors' reply 28
The Role of Therapeutic Endoscopic Ultrasound in Management of Malignant Double Obstruction (Biliary and Gastric Outlet): A Comprehensive Review with Clinical Scenarios 28
Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors 28
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 28
Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity 28
Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: A multicentre retrospective study 27
Small Bowel Ultrasound beyond Inflammatory Bowel Disease: An Updated Review of the Recent Literature 27
Transforming Gastrointestinal Diagnosis with Molecular Endoscopy: Challenges and Opportunities 27
Cell Blood Count Alterations and Patterns of Anaemia in Autoimmune Atrophic Gastritis at Diagnosis: A Multicentre Study 27
Endoscopic management of gastric, duodenal and rectal NETs: Position paper from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Society of Gastroenterology (SIGE), Italian Society of Digestive Endoscopy (SIED) 27
Clinical challenge for gastroenterologists–Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review 27
Clinical and biological heterogeneity of Grade 2 digestive neuroendocrine neoplasms: prognostic significance of the 10% Ki-67 index cutoff and implications for treatment strategies. A longitudinal study 27
Chromogranin A and other enteroendocrine markers in inflammatory bowel disease 27
Plasma chromogranin A in patients with inflammatory bowel disease 27
Paradoxical association between dyspepsia and autoimmune chronic atrophic gastritis: Insights into mechanisms, pathophysiology, and treatment options 27
Nutritional deficiencies in inflammatory bowel disease : therapeutic approaches 27
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 27
Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future 27
Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: the importance of tumor cell differentiation 26
Endoscopic Resection for Duodenal Neuroendocrine Neoplasms between 10 and 20 mm—A Systematic Review and Meta-Analysis 26
Neuroendocrine neoplasms of rectum: A management update 26
Circulating Markers in Gastroenteropancreatic Neuroendocrine Tumors (GEP NETs) 26
Transient elastography assessment of the liver stiffness dynamics during acute hepatitis B 26
Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study 26
Gastric carcinoids : between underestimation and overtreatment 26
Intermittent treatment of recurrent type-1 gastric carcinoids with somatostatin analogues in patients with chronic autoimmune atrophic gastritis 26
Gastrinoma and neurofibromatosis type 2: the first case report and review of the literature 25
Hepatic pseudocystic metastasis of well-differentiated ileal neuroendocrine tumor : a case report with review of the literature 25
Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies 25
Circulating Biochemical Markers of Gastro-Entero-Pancreatic (GEP) Neuroendocrine Neoplasms(NENs) 25
Chromogranin A levels in chronic liver disease and hepatocellular carcinoma 25
The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis 24
Understanding short bowel syndrome : current status and future perspectives 24
Gastric neuroendocrine neoplasms and proton pump inhibitors : fact or coincidence? 24
Prevalence of Disease-Related Malnutrition and Micronutrients Deficit in Patients with Inflammatory Bowel Disease: A Multicentric Cross-Sectional Study by the GSMII (Inflammatory Bowel Disease Study Group) 24
Clinical Outcome of Patients with Gastric, Duodenal, or Rectal Neuroendocrine Tumors after Incomplete Endoscopic Resection 24
Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: A systematic review and meta-analysis 24
Neuroendocrine tumors of the gastro-entero-pancreatic system 24
Somatostatin analogues in functioning gastroenteropancreatic neuroendocrine tumours : Literature review, clinical recommendations and schedules 23
Totale 3.493
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.661
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.661
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 1 1 0 0 0 0 0
2021/20223 0 0 0 1 0 1 0 0 0 0 0 1
2022/202360 16 5 3 4 2 9 7 6 4 0 0 4
2023/202448 0 3 2 6 5 6 3 4 3 1 5 10
2024/20251.512 25 2 5 122 41 129 299 98 206 282 137 166
2025/20263.249 529 589 538 848 600 145 0 0 0 0 0 0
Totale 4.878